Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience
[1] School of Medicine, University of Zagreb, Zagreb, Croatia
[2] Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Pulmonology, Zagreb, Croatia
[3] Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia
[4] Solmed Group, Department: Poliklinika Solmed, Zagreb, Croatia
[5] Department of Anesthesiology, Intensive Care Medicine and Pain Management, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
[6] Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Clinical Immunology and Rheumatology, Zagreb, Croatia
[7] Polyclinic for Respiratory Diseases, Dom zdravlja Zagreb - Zapad, Zagreb, Croatia
[8] Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Croatia
[9] School of Dental Medicine, University of Zagreb, Zagreb, Croatia
This is a correction of Biochem Med (Zagreb) 2023;33(2):020704. DOI: https://doi.org/10.11613/BM.2023.020704
Since the publication of the article, the authors have noticed that their first names and surnames in the by-line were listed in reverse. The correct by-line is presented above. We apologize to the authors for any inconvenience caused to the readers.
